Serum AMH concentrations showed the best consistency, with AFC as second best.

Wider implications of the findings: Age-specific AMH levels are predictive for ANM.

At any given age, considerable interindividual differences in serum AMH levels were observed.

Objective: This study was an assessment of serum AMH levels in healthy females.

The combination of AMH and AFC, without age, had similar accuracy.

Antral follicle count and AMH significantly added prognostic value to this.

Fertility was explored according to pregnancies achieved, semen analysis, and AMH.

AMH emerged as a superior indicator of blastocyst development compared to basal FSH.

The analysis based on AMH as a tool for dose individualization suggested comparable results.

AMH measurements were performed free of charge by Roche Diagnostics.

For the prediction of nonpregnancy, poor performance for both AMH and AFC was found.

Unlike in our previous publication however, a declining AMH effect with increasing age was observed.

This declining AMH effect is in line with recent long-term follow-up data published by others.

These results allow us to propose a revised and extended experimental phase diagram of AMH.

Currently, the molecular identity of downstream events regulated by the AMH signaling pathway remains unclear.

After adjusting for age, only AMH and inhibin B were significantly associated with cycle irregularity.